Profil
Alain Bernard is currently the Chief Technology Officer at VectivBio Holding AG since 2019.
Prior to this, he worked as the Head-Global Biotech Process Development at R-Pharm JSC from 2017 to 2019, Vice President-Biopharmaceutical Process Sciences at UCB SA from 2006 to 2016, and Director-Biotech Process Development at Merck Serono SA from 2002 to 2006.
Dr. Bernard holds a doctorate degree from the Massachusetts Institute of Technology.
Ehemalige bekannte Positionen von Alain Bernard
| Unternehmen | Position | Ende |
|---|---|---|
R-Pharm JSC
R-Pharm JSC BiotechnologyHealth Technology Engages in research, development and manufacturing of medicines & wholesales medical supplies | Corporate Officer/Principal | 01.07.2019 |
| UCB | Corporate Officer/Principal | 01.01.2016 |
Merck Serono SA
Merck Serono SA Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for reproductive and metabolism | Corporate Officer/Principal | 01.11.2006 |
| VECTIVBIO HOLDING AG | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Alain Bernard
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
UCB SA
UCB SA Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Merck Serono SA
Merck Serono SA Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for reproductive and metabolism | Health Technology |
R-Pharm JSC
R-Pharm JSC BiotechnologyHealth Technology Engages in research, development and manufacturing of medicines & wholesales medical supplies | Health Technology |
VectivBio Holding AG
VectivBio Holding AG Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for rare diseases | Health Technology |
















